Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy
Camilla Schou Andersen1, Chunyuan Fei, Michael Gamborg
1Institute of Preventive Medicine, Copenhagen University Hospital, Copenhagen, Denmark. csl@ipm.regionh.dk
Insights
Maternal exposure to persistent chemicals like perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) was linked to lower infant weight and BMI. These effects were more significant in baby boys during their first year of life.
Area of Science:
- Environmental Health
- Pediatric Health
- Toxicology
Background:
- Perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) are persistent organic pollutants.
- Early-life exposure to these chemicals may impact child development.
- Understanding these associations is crucial for public health.
Purpose of the Study:
- To investigate the relationship between maternal plasma concentrations of PFOS and PFOA and infant growth.
- To assess the impact on infant weight, length, and body mass index (BMI) during the first year of life.
Main Methods:
- Analysis of maternal blood samples from the Danish National Birth Cohort.
- Inclusion of 1,010 mother-infant pairs with available anthropometric data at 5 and 12 months.
- Application of multiple linear regression models to determine associations.
Main Results:
- Maternal PFOS and PFOA levels showed an inverse association with infant weight and BMI.
- These associations were more pronounced in male infants compared to female infants.
- No significant associations were found between these chemical exposures and infant length.
Conclusions:
- Maternal exposure to PFOS and PFOA may negatively affect infant growth, particularly weight and BMI.
- Sex-specific differences in susceptibility to these chemical exposures were observed.
- Further research is warranted to understand the long-term implications of early-life exposure to persistent chemicals.
Abstract:
Perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) are persistent chemicals that may affect growth early in life. The authors estimated the associations between maternal plasma levels of PFOS and PFOA and infants' weight, length, and body mass index development during the first year of life. Fourteen hundred women were randomly selected from the Danish National Birth Cohort among those who provided blood samples early in pregnancy and gave birth to liveborn singletons between 1996 and 2002. Weight and length information at 5 and 12 months of age was available for 1,010 children. Multiple linear regression models were used for analyses, and maternal PFOS and PFOA concentrations (ng/mL) were inversely related to children's weight in the first year of life: adjusted regression coefficients: 0.8 g (95% confidence interval(CI): 4.2, 2.6) at 5 months and 5.8 g (95% CI:10.4, 1.2) at 12 months for perfluorooctanesulfonate(PFOS); 9.4 g (95% CI: 28.6, 9.9) at 5 months and 19.0 g (95% CI: 44.9, 6.8) at 12 months for perfluorooctanoate(PFOA) [corrected]. A similar pattern was observed for body mass index measurements, and no associations with length were found. After sex stratification, the inverse associations with weight and body mass index were more pronounced in boys, and no clear association was seen for girls.
Related Concept Videos
Development of the Oral Microbiota
Teratogenicity
Environmental Influences on Intelligence


